Entities

Michael Cooney, PhD is publicly listed by Bain Capital Life Sciences as Vice President. Genetics research at Harvard and vaccine development at Genocea Biosciences.

Melaku Arega, MD is publicly listed by Bain Capital Life Sciences as Vice President. Clinical training at Harvard Medical School and research on disparities in cancer care.

Chiaka Ibe is publicly listed by Bain Capital Life Sciences as Associate. Earlier healthcare consulting at Bain & Company and analysis at Gates Ventures.

Adam M. Koppel is publicly listed by Bain Capital Life Sciences as Partner. Former Biogen strategy executive; trained in medicine and neuroscience. Bain Capital Life Sciences’ current own biography confirms Adam M. Koppel, MD, PhD as Partner, initially joining Bain in2003 and returning in2016 after serving as Biogen’s Executive Vice President of Corporate Development and Chief Strategy Officer. His prior work included Bain public-equity healthcare investing and McKinsey consulting. He received an MD and a neuroscience PhD from the University of Pennsylvania, an MBA from Wharton as a Palmer Scholar, and AB/AM degrees in history and science from Harvard. Synapticure’s February2022 seed announcement names Adam Koppel personally with Bain Capital as an identity qualifier. The exact middle-initial/degree/employer bridge identifies the retained Adam M. Koppel record; no separate Adam Koppel alias or Bain corporate check is created.

Molly Lawrence is publicly listed by Bain Capital Life Sciences as Vice President, Human Resources, Life Sciences. Directs recruiting and employee development for life sciences, following talent roles at Audax.

Alyson Goff is publicly listed by Bain Capital Life Sciences as Associate. Works in the life sciences Portfolio Group; earlier consulting experience at Guidehouse.

Or Alon has extensive experience in analyzing, modelling and structuring intricate debt financing, including complex financial covenants and structures, across a range of corporations – from small, venture-backed pre-revenue startups to mature, cashflow-positive companies.

Nicholas Downing is publicly listed by Bain Capital Life Sciences as Partner. Trained as a physician and previously worked in strategic consulting at McKinsey.

Amarilice Young is publicly listed by Bain Capital Life Sciences as Associate General Counsel. Previously a partner in Goodwin Procter’s life sciences practice.

Will Cozean is publicly listed by Bain Capital Life Sciences as Managing Director. Earlier healthcare investing with Bain’s private equity team and operational consulting at McKinsey.

Andrew Hack, MD, PhD is publicly listed by Bain Capital Life Sciences as Partner. Former CFO of Editas Medicine, with healthcare public-market investment experience.

Josh Hersch is an Investment Partner and Head of Portfolio Management at OurCrowd, where he leads the firm’s portfolio management team.

Anna serves as Chief Legal Officer and Corporate Secretary where she oversees all legal, regulatory, compliance and employment matters across OurCrowd’s investment activities and operations.

Semil Shah founded Haystack in2013 and is its founding partner. His own firm and personal biographies identify early investments in DoorDash,Instacart,Figma,HashiCorp andAppliedIntuition, and previous startup product/operational work including a business acquired byApple. His own current biography also identifies a LightspeedVenturePartners venture-partner affiliation since2018; priorGoldilocks role/reference remains preserved. He writes about technology and seed investing, and hisApril2026 fund announcement describes Haystack’sVIII and NeedlesIII fundraising. His self-published author avatar provides an authentic portrait, visually verified. Investment biographies do not establish individual cash allocations to his manager’s companies.

Elijah Sutanto is a partner at Lightspeed Venture Partners in San Francisco, investing across the AI stack: software and hardware infrastructure, applications, and security. He previously invested at Coatue across venture and growth. He is retained here with a historical Coatue role; his current Lightspeed role is preserved.

John Trzupek, PhD is publicly listed by Bain Capital Life Sciences as Managing Director. Previously held executive roles at Abata Therapeutics and KSQ Therapeutics and scientific roles at Pfizer.

Garry Tan is publicly listed by Initialized Capital as Founder & Board Partner. Founded Initialized and remains a board partner; separately leads Y Combinator.

Isaac Cheng is publicly listed by Bain Capital Life Sciences as Vice President. Pharmaceutical strategy and business development at Johnson & Johnson and AbbVie.

Founded MuleSoft and led it from an open-source project to IPO and acquisition by Salesforce. Supports DIG founders on product, hiring and go-to-market. Also published as a Lightspeed venture partner.

Co-founder and president of Stripe.

Co-founder and CEO of Stripe.

AI and genomic-medicine researcher who founded Deep Genomics in 2015 and co-founded the Vector Institute; his research spans deep learning and genetic medicine.

Autism Impact Fund co-founder who founded the recruiting firm CPI in 1996. Previously worked in real estate at Jones Lang LaSalle and Morgan Stanley; graduated from Denison University. Distinct from the life sciences executive and Deep Genomics CEO of the same name.

Life-sciences finance executive with prior CFO experience at ImmunoGen, Aveo Oncology and Genzyme Biosurgery. Published in his biography as David B. Johnston.

Biotechnology scientist with experience in cell biology, screening and therapeutic discovery at Arbor, Obsidian, Sana and Novartis.

Oriol Vinyals is a Frontier AI Partner at 224 Ventures, participating in sourcing, evaluation and voting on investments. The firm’s launch identifies him as a Discovery Loop co-founder and former Gemini co-lead at Google DeepMind.

Operations executive with experience in medical devices, contract research and healthcare design; founded Caregiver Support Technologies.

Novo Holdings A/S is a Danish holding and investment company, CVR24257630, responsible for managing the assets and wealth of its owner, the Novo Nordisk Foundation. It is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S, while remaining a distinct investment institution from those operating companies and from the charitable foundation. It invests directly across company stages through Seed, Venture, Principal, Planetary Health and Asia teams, alongside a diversified Capital Investments portfolio. Life-science investments span therapeutics, medical devices and healthcare technologies; quantum investments and AI-driven biotechnology are relevant deep-technology themes. Its in-house SeedLab and entrepreneurs-in-residence support scientific company formation. Novo Holdings is headquartered in Hellerup, Denmark, with published offices in London, Boston, San Francisco, Singapore, Shanghai and Mumbai. Kasim Kutay is its currently published CEO. Public-directory staff, legal regional consultancy entities, external Advisory Group members and board directors are explicitly qualified in their respective affiliations. The current directory contains 267 named profiles; it includes two distinct Jessica Lis and genuine published biography/portrait gaps. The foundation owner provides the investment capital. Reported total assets under management, annual capital deployment, strategy asset values and prospective investment commitments are not closed third-party LP funds. As of year-end2025 its reported total assets under management were DKK694billion / EUR93billion. No LP fund cash close is inferred from that figure. Existing institutional and personal investment records are preserved. Its REPAIR Impact Fund is a Novo Nordisk Foundation-commissioned investment programme established in February2018 with a USD165million budget, currently supporting its existing12-company portfolio. That programme budget is not a third-party LP fund cash close. Its dedicated quantum team operates within Seed Investments; November2025 reporting distinguishes approximately EUR100million already invested from a EUR188million long-term commitment. Investments into externally managed55North, QuantonationII and PlaygroundGlobalIV do not make Novo Holdings those funds’ manager.

Legacy database investment-attribution alias for the Daiichi Life operating insurer, supported by its original dai-ichi-life.co.jp/english URL and Neurotrack2019 buyer source. The exact insurer is now Daiichi Life Insurance Co., Ltd., formerly The Dai-ichi Life Insurance Company, Limited; its full41-person public leadership profile is retained under Company GoldiDaiichiLifeInsuranceCompanyLimited / Investor4581. The inherited immutable InvestmentFirm type here does not make the insurer a standalone VC manager. This alias is not reinterpreted as the separate parent Daiichi Life Group, Inc., and its protected mirror-round18150 attribution remains unchanged. No blanket merge, duplicate private investor, new fund or additional cash check is performed.

Operating software company developing platforms for integrating data, decisions and operations. Corporate investments do not make the parent a conventional venture capital fund.

QuantumLight is a London-based venture and growth investment firm backing private technology companies globally. It develops Aleph, an internal machine-learning system that screens and ranks venture-backed businesses using company and market data to guide investment sourcing and assessment. Its portfolio spans AI models, computing infrastructure, developer tools, cybersecurity, financial technology and healthcare software. Portfolio founders receive operating support and playbooks based on Revolut’s experience in hiring, talent management and scaling businesses. The website is operated by Quantum Light Management Ltd, a UK investment manager; Aleph is an investment tool rather than a separately verified commercial product for outside customers.

Rethink Impact is a venture-capital manager backing women-led technology businesses addressing health, education and workforce, financial services, and sustainability. Its current strategy targets software and AI-enabled companies from Seed through Series C; the advertised company fundraising range is a strategy criterion, not a disclosed investment ticket. The firm’s own legal terms identify Rethink Impact Management, LLC, also named as investment manager in SEC filings for Funds II and III. The current own directory names six people: founder and managing partner Jenny Abramson, managing partner Heidi Patel, platform leader Chelsea Morris, principals Joe Garcia and Jill Ni, and finance/operations associate Braxton Sandman. Affiliated Rethink Capital Partners and historical Seavest entities have distinct legal capacities; their funds, public rosters and treasury are not merged with this retained investor. Rethink Education and Rethink Ventures remain separate existing profiles. Its public portfolio includes cognitive-health company Neurotrack and mental-health, healthcare, robotics and software businesses such as Spring Health, Seven Starling, Parallel Learning, Andromeda Robotics, AllSpice.io, Clarity Pediatrics and Nectir. The first fund’s 2017 close was announced above $110 million, but its exact corpus and full closing day remain unverified. Fund II’s publicly reported July2020 close was $182 million, with a full cash closing day unpublished. Fund III’s September12,2024 announcement above $250 million is refined by the February12,2025 SEC amendment reporting $259,766,000 sold with none remaining, rather than creating another fundraise. Manager AUM, UBS client commitments and portfolio-company valuations are separate from total fund closes and investee cash. All existing investment records and historical aliases are retained.

UPMC Enterprises is the Pittsburgh-based innovation, commercialization and venture capital division of UPMC, the integrated health care provider and insurer. Formed in 2015, it invests corporate capital and builds businesses across digital solutions, translational life sciences and medical technology. Its portfolio includes health care AI, clinical data platforms, diagnostics and therapeutics, including neuroscience and neuroinflammation. It works with UPMC clinicians and researchers and the University of Pittsburgh to develop and test products, commercialize discoveries, and support companies from early through growth stages globally. The division’s evergreen model provides portfolio companies capital, clinical connections, technical services and operating support. The announced January 2020 USD1 billion life-sciences deployment commitment includes an earlier USD200 million immunotherapy initiative; it is a corporate investment commitment, not a independently verified external limited-partner fund closing or proof that the entire commitment was deployed. UPMC Enterprises is retained as the institutional buyer, distinct from its parent health system, clinical customers and individual executives.

Tokyo-based venture capital firm investing across seed through growth stages in companies in Japan and globally that can contribute to Japan’s next generation of businesses. Its investments span enterprise software, AI, fintech, semiconductors, fusion energy, robotics, aerospace and biotechnology. Coral combines capital with recruiting support, a founder community, investor introductions and operating knowledge. Its team traces its first fund to 500 Startups Japan in 2016; Coral Capital IV closed in May 2024 with ¥25 billion for seed-to-Series C investments and continued backing of companies funded by its earlier vehicles.

Co-founder and production leader at Karma Biotechnologies, where he develops lipid-nanoparticle therapeutics.

Co-founder and CFO of Mariana Minerals.

Co-founder and COO of Mariana Minerals.

Chief financial officer at cultivated-meat company Vow; previously at Karma Biotechnologies.

Karma Biotechnologies is a Los Angeles biotech company founded in 2017. It developed lipid-nanoparticle immunotherapies (Xavine) aimed at autoimmunity and solid tumors. Founders include Andrew Gray (CEO), Alan Johnson (COO) and Joseph Turner. PitchBook lists the company as out of business as of 25 Jul 2025.

Co-founder and CTO of Mariana Minerals.

Co-founder and CEO of Mariana Minerals; formerly at Tesla.

Hello Heart’s digital coaching app helps people manage heart health, and drives high employee engagement while potentially reducing medical claims costs.

Company operating in Food & Agriculture.

Farming is unpredictable. Our arginine-powered crop nutrition works with plant biology to activate roots, help growers produce more with less.

Deep Genomics is a biotechnology company using biological foundation models and laboratory experiments to discover and design genetic medicines. Its BioFM platform links model training, predictions and experimental validation in repeated laboratory feedback cycles. BigRNA models RNA biology and the effects of sequence variants; REPRESS predicts microRNA binding and RNA degradation; DeepADAR supports guide-RNA design for RNA editing. The company uses these models for target discovery, molecular design and evaluation of potential off-target effects, working on internal therapeutic programs and with pharmaceutical partners. These are research and drug-discovery capabilities, not an assertion of an approved medicine.

Tokyo-based venture capital firm founded in July 2000 within the Itochu group. It invests from early to middle stages in technology startups, combining independent venture investment decisions with the group’s customer networks and international business resources. Its portfolio spans AI software, enterprise technology, healthcare, robotics, space and other deep technologies in Japan and overseas. The firm provides hands-on business development and market-expansion support. Its sixth fund completed fundraising at ¥16.1 billion in March 2025.

Kernel operates in Biotech & Life Sciences.

Light Field Lab operates in Hardware & Semiconductors.

Rosebud AI operates in Fintech.

Vista AI Scan is FDA-cleared, AI-powered software that automates cardiac MRI for faster, more consistent scans across supported MRI machines.

F5 Distributed Cloud Services deliver security, WAAP, API protection, and multicloud networking across cloud, on-premises, Kubernetes, and edge. Learn more today.

SingleStore is the real-time database for AI, apps and analytics. Build intelligent experiences with live reads and writes, one engine for transactions and analytics, and open data access.

Test your gut microbiome and measure your health down to the molecular level.

Company operating in Developer Tools.

Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.

Reduce staff burnout, improve community engagement, and drive better patient outcomes. That’s the power of clinical AI from Limbic.

Company operating in Construction.

Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.

The runtime AI data control platform for enterprises. Skyflow sanitizes data on ingest, protects it at runtime, and enforces policy so you can ship AI safely.

Symbolica. Intelligence, Redefined.

The clinical AI partner to NHS systems - safe, regulated, proven at scale across 2.5 million consultations.

Indian labor-marketplace and staffing platform using conversational AI and assisted workflows to recruit and onboard blue- and grey-collar workers at scale.

We are building a future where biology is no longer destiny, but design.

Company operating in Healthcare.

Position Ventures is a San Francisco early-stage venture capital firm founded and led by Jenny He. It combines startup investing with positioning and communications support, helping founders explain their businesses to potential hires, investors and partners. Its public portfolio includes AI and developer-infrastructure companies such as Twelve Labs, Cartesia, Patlytics, Accordance, Propel Code, Lantern and Nova AI, alongside broader enterprise and consumer technology businesses. Bridge Neurotech independently names Position Ventures among its backers, establishing a neuroscience investment connection without disclosing its particular round or ticket. SEC filings identify the legal adviser as Position Ventures, LLC (CRD 316779), Jenny He as its managing member, and four associated venture-fund or series vehicles. Fund II reported USD5.46 million sold to 23 investors by July 2026; this partial offering disclosure does not establish a final fund close. Its sole publicly named current investment professional is founder and general partner Jenny He. Founder testimonials and portfolio-company operators are distinguished from fund employees.

Craft & play any story! Players can collaborate, craft, and explore an ever-growing collection of playable places with unique, AI-driven game mechanics and diverse characters.

Hire event staff and warehouse talent near you, fast. WorkWhile connects businesses with reliable, flexible professionals for logistics, production, and events.

Join Astrus to improve global computation by building AI-powered tools for chip designers.

BrightAI deploys autonomous AI devices, edge sensors, and foundation models to transform critical infrastructure from reactive to proactive. Maximize asset life and eliminate catastrophic downtime.

Construction-software company developing AI tools for workforce automation and pre-construction workflows.

Company operating in AI.

Neurosymbolic agentic AI that automates finance, AP, healthcare, and IT workflows in plain English, with zero hallucinations and full audit compliance. Recognized by Gartner, trusted by PepsiCo and Wipro.

LifeArc Ventures is the venture investment activity of LifeArc, a self-funded UK medical research organisation and charity. Based in London, it invests in seed-to-SeriesB therapeutics, medtech and health-technology companies globally and operates both direct-company and life-sciences fund investment strategies. Its team combines clinical, scientific, commercial and investment experience. Relevant holdings include Exciva, AviadoBio, Pheno Therapeutics, Function RX, Cumulus Neuroscience and Fluid Biomed. Investment returns support LifeArc’s long-term financial sustainability and patient-impact mission.

a research lab focused on pushing the frontiers of creativity through deep learning.

Frontier AI for tax, audit & accounting teams. Multi-agent research platform built by Stanford AI Lab for CPAs and tax professionals.

Verve Ventures is a Swiss venture-capital investor backing European science and technology companies. Its three investment themes are the future of computing, frontiers in health and biology, and resilience in energy and resources. It invests in early-stage founders turning research into commercial products and supports portfolio companies with technical expertise, fundraising and business connections. Verve Capital Partners AG operates its regulated investment platform, giving private and institutional investors access to venture investments while holding client assets separately from its own balance sheet.

a2z Radiology AI — one AI that triages seven urgent abdomen-pelvis CT findings and moves the flagged studies up the worklist. FDA-cleared, with image-to-report drafting in research.

Discover Viven.ai – the cutting-edge platform creating Digital Twins for enterprises and you! Empower your team with personalized AI models that retain knowledge, enhance collaboration, and drive productivity.

Developer Tools company.

RunSybil is an autonomous offensive security solution. Find exploitable vulnerabilities before a breach, eliminate noise, and remediate at enterprise scale.

We build a new class of models that can perceive, predict, and act in virtual and physical environments.

Turn your idea into a business in minutes. Nas.com helps you create, launch, and sell.

Pramaana Labs is a frontier AI lab building the verification layer for high-stakes AI. We turn complex domain knowledge into machine-checkable systems that return proofs, counterexamples, and traceable explanations.

AI enablement, security, and control in one platform.

Operator-led, AI-focused venture capital firm investing across the US–India corridor and supporting founders with hands-on company-building expertise.

Build, deploy, and scale AI agents for clinical and administrative work. The platform leading health systems run on.

AI-powered compliance automation built for regulated industries. From prevailing wage to project closeout.

Mariana Minerals is a software-first, vertically integrated critical minerals company. It engineers, builds and operates mines and refineries using MarianaOS (CapitalProjectOS, MineOS and PlantOS). Founded in 2024. Headquarters in San Francisco with a Houston engineering office. Projects include Copper One (Utah) and Lithium One (Texas).

Company operating in Construction.

Intuition Robotics builds an empathetic digital companion for older adults.

Modern Relay is building AI-native knowledge infrastructure.

Office manager and talent-acquisition lead at Point Nine.

Senior legal associate at Point Nine.

Director of platform and community at Point Nine.

Head of finance at Point Nine.

General counsel at Point Nine.

Senior fund operations manager at Point Nine.

Operating partner at Point Nine.

Research analyst at Point Nine.

Venture partner at Point Nine and co-founder of the original partnership.

Venture partner at Point Nine.

Partner at Point Nine investing in early-stage software.

Co-founder and partner at Point Nine.

Partner at Point Nine investing in early-stage software companies.

ZenML is an open-source MLOps and LLMOps framework that helps teams build reproducible, production-ready ML pipelines across any stack. Its code-first, pipeline-centric approach integrates with popular tools, and a managed cloud adds collaboration, governance, and enterprise support.

Zentist provides an AI-powered dental revenue cycle management platform focused on dental support organizations (DSOs) and multi-site dental practices in the US.

Zype provides an API-first video infrastructure solution that lets media companies manage, monetize, and distribute video content across web, mobile, and other platforms.

Yogaia is an online wellness platform offering live and on-demand yoga, Pilates, strength, and mindfulness classes you can join from anywhere. Founded in Finland in 2013, it pioneered live, interactive sessions with optional camera-on feedback to bring studio energy home.

Zauber is building the AI operating system for logistics, unifying tools like spot rate requests and TMS booking to automate planning and execution across the supply chain. Founded by Erik Muttersbach, co-founder of Forto, one of Europe’s largest digital freight forwarders, Zauber applies deep industry expertise to streamline global freight workflows through an integrated, AI-first platform.

Zenaton was a developer-focused workflow orchestration platform that automated and supervised complex business processes, handling retries and powering event-driven background jobs with simple code across workers and queues.

Zendesk builds customer service and experience software used by businesses to support, engage, and retain customers across email, chat, messaging, voice, and AI. Founded in Copenhagen in 2007 and now headquartered in San Francisco, Zendesk went public in 2014 and was taken private in 2022.

Westwing offers a curated online destination for furniture, lighting, textiles, and accessories, alongside its private-label Westwing Collection. Headquartered in Munich and active across Europe, the company was founded in 2011 and is publicly listed on the Frankfurt Stock Exchange.

Whereby provides secure, no-download video meetings and a developer-friendly video API used across telehealth, education, and customer support. Founded in Norway as appear.in in 2013 and rebranded in 2019, the company focuses on simplicity, customization, and privacy-first design.

Wikifarmer is a global platform that empowers farmers with free, expert-led education and a B2B marketplace to sell directly to verified buyers. It promotes fair, transparent agri-food trade and traceability while helping buyers source quality, sustainably produced goods.

Workerbase helps factories modernize operations with a no-code connected worker suite for digital work instructions, task management, alerts, and data capture – linking people, machines, and IT systems. Manufacturers use it to boost productivity, quality, and agility without rebuilding the shop floor.

UpCodes is a comprehensive building-code compliance platform for architects, engineers, and contractors. Founded in 2016, it unifies searchable codes across jurisdictions, collaboration tools, and Copilot – an AI assistant that answers project-specific code questions with cited sections.

Userfox built tools to design and send behavior-triggered, personalized emails, enabling startups and SaaS companies to onboard, engage, and retain users. The Y Combinator–backed company was acquired by AdRoll in 2014 to expand its CRM and email capabilities.

Founded in Auckland in 2010, Vend built one of the first cloud POS systems for independent retailers, offering inventory, multi-store, loyalty, and real-time reporting. Backed early by Point Nine, Vend was acquired by Lightspeed in 2021, where its technology continues to power modern retail operations.

Vev provides free, modern software for independent professionals and small teams to run service businesses end-to-end. The platform offers online booking, payments, scheduling, team management, and lightweight CRM.

Venture capital firm run by solo investor Mike Chalfen, backing a small number of early-stage European business-to-business software companies. It invests in startups developing new markets and products, including AI, developer infrastructure and enterprise software, and often leads rounds while remaining flexible about syndicate structure. Chalfen works directly with founders on company development and long-term strategy. The firm’s current website distinguishes its own portfolio from investments Chalfen made earlier in his career; career investments are not automatically holdings of Chalfen Ventures.

Teamworthy Ventures is the venture investment business of Teamworthy Group LLC (SEC adviser CRD289766), led by Managing Partner Thomas D. Lehrman. With offices in New York and Nashville, it backs software and technology companies across stages and supports founders with talent, recruiting, product, technology and fellowship programs. Its official directory publishes nineteen core team members and six Venture Partners, distinct from its volunteer Venture Advisor program. AI and deep-technology relevance includes relationship-intelligence company Affinity, autonomous aircraft developer Reliable Robotics, software-testing company Antithesis and operational-technology cybersecurity company Shift5. Teamworthy is legally and operationally distinct from San Francisco venture fund investor Top Tier Capital Partners. This record retains a legacy database ID containing TopTierCapitalPartners to preserve existing protected relationships; the ID is not an alias or legal name. Both managers independently participated in Typeform’s March2022 Series C. SEC filings document real Teamworthy fund vehicles; offering targets and fund gross asset values are not represented as closed capital.

Founded in 2012 as Positionly and later rebranded to Unamo, the company provided an integrated platform for SEO ranking, on-page optimization, and social media monitoring to help teams manage and grow their online presence.

Unbounce, founded in 2009 in Vancouver, was one of the first and leading platforms for building high-converting landing pages without code. Over time it expanded into a conversion intelligence platform, adding several AI tools to further boost performance and ROI.

Paris-based Upciti provides urban intelligence via on‑device computer vision sensors and software that turn real‑time street activity into actionable metrics for traffic, infrastructure, and livability. Used by municipalities worldwide, Upciti processes data locally to protect citizens’ privacy.

Tengo is an AI-powered platform that helps companies find, qualify, and respond to public tenders at scale. It centralizes opportunities, automates analysis and answer drafting, and streamlines collaboration from discovery to submission for faster, higher-quality bids.

Thalamed was a B2B marketplace that helped doctors, clinics, and hospitals find, compare, and purchase medical equipment by requesting quotes from leading manufacturers. Acquired in 2021.

TheBrief (formerly Creatopy) is an AI agency that unifies ad creation, campaign launch, and optimization. It helps teams run ads directly to major channels, generate dynamic creatives at scale, and leverage AI agents for ongoing recommendations and faster, more consistent results.

Founded in Berlin in 2018, Tier built a leading shared micromobility platform for e‑scooters and e‑bikes across Europe and beyond, focused on safe, sustainable urban transport. In 2024, Tier merged with Dott to create one of Europe’s largest operators.